|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
70,932,000 |
Market
Cap: |
2.61(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.81 - $52.44 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
164,376 |
296,877 |
390,685 |
429,469 |
Total Sell Value |
$6,457,019 |
$12,763,246 |
$15,609,906 |
$16,448,857 |
Total People Sold |
7 |
7 |
7 |
8 |
Total Sell Transactions |
10 |
31 |
42 |
61 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-02-12 |
4 |
AS |
$51.38 |
$35,760 |
D/D |
(696) |
11,770 |
|
-30% |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-02-12 |
4 |
AS |
$51.38 |
$81,900 |
D/D |
(1,594) |
7,702 |
|
-30% |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-12 |
4 |
AS |
$51.38 |
$52,562 |
D/D |
(1,023) |
7,467 |
|
-30% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
4,248 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
81,622 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
9,296 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
8,490 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-09 |
4 |
AS |
$48.24 |
$3,615,982 |
D/D |
(71,774) |
2,686 |
|
-28% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-09 |
4 |
OE |
$0.00 |
$1,479,282 |
D/D |
71,846 |
74,460 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,063 |
79,278 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
12,466 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
7,265 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
6,459 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-01 |
4 |
AS |
$45.06 |
$72,817 |
D/D |
(1,616) |
75,215 |
|
-21% |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,925 |
76,831 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-02-01 |
4 |
AS |
$45.06 |
$42,627 |
D/D |
(946) |
10,122 |
|
-21% |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,650 |
11,068 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-01 |
4 |
AS |
$45.06 |
$67,230 |
D/D |
(1,492) |
3,021 |
|
-21% |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,513 |
4,513 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-01 |
4 |
AS |
$45.06 |
$59,659 |
D/D |
(1,324) |
2,614 |
|
-21% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,938 |
3,938 |
|
- |
|
Meeker David P |
President and CEO |
|
2024-02-01 |
4 |
AS |
$45.06 |
$196,507 |
D/D |
(4,361) |
121,099 |
|
-21% |
|
Meeker David P |
President and CEO |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,125 |
125,460 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-12-29 |
4 |
OE |
$6.88 |
$72,240 |
D/D |
10,500 |
71,906 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-12-28 |
4 |
AS |
$50.00 |
$396,318 |
D/D |
(7,926) |
0 |
|
-18% |
|
251 Records found
|
|
Page 2 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|